TenX Keane Acquisition Quote - TENK

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

40.50

Bid

40.50

Ask

15.00

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

269.45M

Previous Close

40.50

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

6,653,077

Dividend Yield

PE Ratio

2.97

Earnings Per Share (EPS)

0.36

Revenue

Net Profit

2.42M

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.citiusonc.com

Headquarters

Dover, Delaware, USA

Founded

2024

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire CRANFORD, N.J., July 10, 2024 Multiple catalysts for potentially transformative assets in second half of...

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the “Company”), announced today that if the proposal to amend the Company’s Amended and...

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post transaction...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, July 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022

New York, NY, Dec. 06, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (Nasdaq: TENKU), a newly incorporated blank check company, today announced that, commencing on December 8...

TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment Option

New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (NASDAQ:TENKU) (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

TENK - Frequently Asked Questions (FAQ)

What is the current TenX Keane Acquisition share price?

The current share price of TenX Keane Acquisition is US$ 40.50

How many TenX Keane Acquisition shares are in issue?

TenX Keane Acquisition has 6,653,077 shares in issue

What is the market cap of TenX Keane Acquisition?

The market capitalisation of TenX Keane Acquisition is USD 269.45M

What is the 1 year trading range for TenX Keane Acquisition share price?

TenX Keane Acquisition has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of TenX Keane Acquisition?

The price to earnings ratio of TenX Keane Acquisition is 2.97

What is the reporting currency for TenX Keane Acquisition?

TenX Keane Acquisition reports financial results in USD

What is the latest annual profit for TenX Keane Acquisition?

The latest annual profit of TenX Keane Acquisition is USD 2.42M

What is the registered address of TenX Keane Acquisition?

The registered address for TenX Keane Acquisition is 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901

What is the TenX Keane Acquisition website address?

The website address for TenX Keane Acquisition is www.citiusonc.com

Which industry sector does TenX Keane Acquisition operate in?

TenX Keane Acquisition operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXUNXU Inc	US$ 2.05 (742.24%)	454.64M
WATTEnergous Corporation	US$ 1.4514 (252.97%)	167.21M
INTZIntrusion Inc	US$ 5.522 (155.65%)	116.05M
JDZGJIADE Ltd	US$ 1.43 (104.23%)	5.75M
CYNCYNGN Inc	US$ 1.17 (86.34%)	61.57M
ABPAbpro Holdings Inc	US$ 2.1874 (-51.28%)	1.47M
TRAWTraws Pharma Inc	US$ 7.60 (-43.37%)	905.47k
SHOTWSafety Shot Inc	US$ 0.122005 (-32.33%)	1.1k
LITMSnow Lake Resources Ltd	US$ 1.125 (-29.69%)	45.23M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	US$ 66.74 (-24.56%)	8.99k
NXUNXU Inc	US$ 2.05 (742.24%)	454.64M
VINCVincerx Inc	US$ 0.332999 (71.65%)	303.66M
XTIAXTI Aerospace Inc	US$ 0.0399 (1.01%)	186.41M
WATTEnergous Corporation	US$ 1.4514 (252.97%)	167.21M
SMXSMX Security Matters Public Company	US$ 0.6088 (72.17%)	140.78M